Clinical Trial Update: CES1 Crossover Trial of Clopidogrel and Ticagrelor [Phase 4]

View source ↗

Summary

Phase 4 crossover trial comparing clopidogrel and ticagrelor in patients with myocardial infarction and thrombotic disorders; results have been posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Platelet Dysfunction
• Thrombosis

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Myocardial Infarction, Thrombosis | Phase 4 | Status: COMPLETED | Results posted: 2024-05-06